Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Melissa E. Hogg"'
Autor:
Nathan Bahary, Naomi Fei, Rajesh Ramanathan, Melissa E. Hogg, Sijin Wen, Brian A. Boone, Herbert J. Zeh, Amer H. Zureikat, Aatur D. Singhi, Michael T. Lotze
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 5, Pp 1822-1829 (2021)
Clinical and Translational Science
Clinical and Translational Science
SMAD4, a tumor suppressor gene, is lost in up to 60%–90% of pancreatic adenocarcinomas (PDAs). Loss of SMAD4 allows tumor progression by upregulating autophagy, a cell survival mechanism that counteracts apoptosis and allows intracellular recycling
Autor:
Melissa E. Hogg, Mark S. Talamonti, Charles C. Vining, Kevin K. Roggin, Kristine Kuchta, Darryl Schuitevoerder, Pierce Paterakos, Yaniv Berger
Publikováno v:
Journal of Surgical Oncology. 122:183-194
Background Reports on the safety of minimally invasive pancreaticoduodenectomy compared to open pancreaticoduodenectomy (OPD) have demonstrated mixed results. One study comparing robotic pancreaticoduodenectomy (RPD) vs OPD demonstrated decreased com
Autor:
Mazen S. Zenati, Amer H. Zureikat, Melissa E. Hogg, Amr I. Al Abbas, Herbert J. Zeh, Jae Pil Jung, Caroline J. Reiser, Ahmad Hamad
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Optimal cut-offs for CA19-9 response after neoadjuvant therapy (NT) for pancreatic adenocarcinoma (PDAC) are not well characterized. This study aims to analyze the relationship of serum CA19-9 with other markers of response and identify
Autor:
Brian A. Boone, Joal D. Beane, Mazen S. Zenati, Herbert J. Zeh, A. James Moser, Melissa E. Hogg, David L. Bartlett, Amr I. Al Abbas, Amer H. Zureikat
Publikováno v:
Ann Surg
OBJECTIVES: This study aims to present the outcomes of our decade-long experience of robotic pancreatoduodenectomy and provide insights into successful program implementation. BACKGROUND: Despite significant improvement inmortality over the past 30 y
Autor:
Samer AlMasri, Mazen Zenati, Abdulrahman Hammad, Ibrahim Nassour, Hao Liu, Melissa E. Hogg, Herbert J. Zeh, Brian Boone, Nathan Bahary, Aatur D. Singhi, Kenneth K. Lee, Alessandro Paniccia, Amer H. Zureikat
Publikováno v:
JAMA Network Open. 5:e2218355
Neoadjuvant therapy is increasingly used in localized pancreatic carcinoma, and survival is correlated with carbohydrate antigen 19-9 (CA19-9) levels and histopathologic response following neoadjuvant therapy. With several regimens now available, the
Autor:
Melissa E. Hogg, Amir A. Borhani, Herbert J. Zeh, Juliana Tobler, Ahmad Hamad, Mazen S. Zenati, Amer H. Zureikat, Patrick R. Varley, A. Klobuka
Publikováno v:
HPB. 21:695-701
We sought to investigate whether robotic pancreatoduodenectomy (RPD) mitigates adverse outcomes in patients with high-risk morphometric features compared to the open approach (OPD).Morphometric parameters for RPD and OPDs were measured by two blinded
Autor:
Mordechai Rabinovitz, J. Wallis Marsh, Melissa E. Hogg, Asif Khalid, Rohit Das, Allan Tsung, Aatur D. Singhi, David A. Geller, Kenneth K.W. Lee, Kenneth E. Fasanella, James F. Pingpank, Abigail I. Wald, Michael A. Nalesnik, N. Paul Ohori, Adam Slivka, Amer H. Zureikat, Savreet Sarkaria, Randall E. Brand, Anil K. Dasyam, Jennifer Chennat, M. Samir Ayasso, David L. Bartlett, Nathan Bahary, Herbert J. Zeh, Marina N. Nikiforova, Abhinav Humar, Sara E. Monaco, Georgios I. Papachristou, Kevin McGrath
Publikováno v:
Gut. 69:52-61
ObjectiveDespite improvements in imaging, serum CA19-9 and pathological evaluation, differentiating between benign and malignant bile duct strictures remains a diagnostic conundrum. Recent developments in next-generation sequencing (NGS) have opened
Autor:
Amr Al-abbas, Melissa E. Hogg, Caroline J. Rieser, Matthew D. Neal, Amer H. Zureikat, Mazen S. Zenati, Brian A. Boone, Ahmad Hamad, Herbert J. Zeh
Publikováno v:
Annals of Surgical Oncology. 26:1503-1511
Pancreatic ductal adenocarcinoma (PDA) is associated with a hypercoagulable state, resulting in a high risk of venous thromboembolism (VTE). Risk of VTE is well established for patients receiving chemotherapy for advanced disease and during the perio
Autor:
Deepa Magge, Amer H. Zureikat, Ahmad Hamad, Mazen S. Zenati, Herbert J. Zeh, Melissa E. Hogg, Caroline J. Rieser
Publikováno v:
HPB. 20:1172-1180
NSQIP data show that half of distal pancreatectomies (DP) are performed by a minimally invasive approach (MIS). Advantages have been demonstrated for MIS DP, yet comparative cost data are limited. Outcomes and cost were compared in patients undergoin
Autor:
Kenneth K.W. Lee, Alessandro Paniccia, Katelyn Smith, Mazen S. Zenati, Melissa E. Hogg, Amr I. Al Abbas, James A. Brown, Amer H. Zureikat, Asmita Chopra, Herbert J. Zeh, Richard L. Simmons
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 24(7)
Long-term complications following pancreatoduodenectomy (PD) can significantly impact quality of life and healthcare utilization. Most reports focus on short-term (within 90 days) PD outcomes; however, the incidence and risk factors for long-term com